Prostate Cancer - Results from #80

First-line talazoparib plus enzalutamide versus placebo plus enzalutamide in men with metastatic castration-resistant prostate cancer and homologous recombination repair gene alterations: patient-reported outcomes from the randomised, double-blind, placeb April 8, 2025

First-line talazoparib plus enzalutamide versus placebo plus enzalutamide for metastatic castration-resistant prostate cancer: patient-reported outcomes from the randomised, double-blind, placebo-controlled, phase 3 TALAPRO-2 trial. April 8, 2025

Study of persistence and adherence to ADT in prostate cancer: relugolix, degarelix, and GnRH agonists in the US. April 8, 2025

New Study Published in Clinical Cancer Research Validates PROSTOX ultra Diagnostic Test for Predicting Radiation-Induced Late Toxicity in Prostate Cancer April 7, 2025

Validation and Derivation of MicroRNA-based Germline Signatures Predicting Radiation Toxicity in Prostate Cancer April 7, 2025

Real-world utilization patterns and survival in men with metastatic prostate cancer treated with Radium-223 in the United States. April 7, 2025

Identifying Patients at Risk of Early Lethal Prostate Cancer by Integrating Family History, Polygenic Risk Score, Rare Variants in DNA Repair Genes, and Lifestyle Factors. April 7, 2025

A Randomized Comparison of High Dose Rate and Low Dose Rate Prostate Brachytherapy Combined with External Beam Radiotherapy for Unfavourable Prostate Cancer: Efficacy Results after Median Follow-up 74 Months. April 7, 2025

Long-term outcomes of PSMA PET/CT-guided radiotherapy in biochemical failure patients post-radical prostatectomy: a 5-year follow-up analysis. April 7, 2025

Impact of obesity on prostatectomy outcomes: Insights from a large prospectively maintained cohort. April 7, 2025

Detection of MRI-Invisible Disease Using PSMA PET/CT in a Patient Considering Focal Therapy. April 4, 2025

LHRH Antagonists Restore Serum Testosterone Faster Than LHRH Agonists in Prostate Cancer Patients After Radiotherapy. April 4, 2025

Stereotactic body radiotherapy for lung oligometastatic prostate cancer: An international retrospective multicenter study. April 4, 2025

Analytical and Real-World Clinical Characterization of S2,3PSA% Test in MRI Fusion Targeted Prostate Biopsy Population. April 4, 2025

Geographic, socioeconomic and demographic inequalities in the incidence of metastatic prostate cancer at time of diagnosis in England: a population-based evaluation. April 4, 2025

High-Purity CTC RNA Sequencing Identifies Prostate Cancer Lineage Phenotypes Prognostic for Clinical Outcomes. April 3, 2025

Toward a Refined PI-RADS: The Feasibility and Limitations of More Informative Metrics in Reviewing MRI Scans. April 3, 2025

Early changes of PSMA PET expression after initiation of androgen receptor signaling inhibitors in CRPC: an international multicenter retrospective study. April 3, 2025

Targeting the tumour cell surface in advanced prostate cancer. April 3, 2025

Enzalutamide in biochemically recurrent prostate cancer: key findings from the EMBARK study. April 3, 2025

Page 5 of 1473